Source : The Singapore Economic Development Board (EDB)

For Edwards Lifesciences, Singapore plays a central role in its global manufacturing and supply chain strategy. The company’s state-of-the-art facility in Changi is not only its largest manufacturing site outside the United States, but also a key node supporting the production of life-saving heart valve therapies for global markets.

Backed by Singapore’s strong talent base, advanced infrastructure, and strategic trade connectivity, Edwards Lifesciences continues to expand its operations to meet growing global demand. The country’s reputation for reliability, innovation, and quality has made it an integral partner in supporting Edwards Lifesciences’ mission to improve patient outcomes worldwide.